Loading...

Charles Zaloudek, MD

TitleProfessor
InstitutionUniversity of California San Francisco
DepartmentPathology
Address1825 4th Street
San Francisco CA 94158
Phone415-353-1734
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Johns Hopkins UniversityM.D.1971School of Medicine

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wolsky RJ, Price MA, Zaloudek C, Rabban JT. Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa? Int J Gynecol Pathol. 2018 May; 37(3):262-274. PMID: 28700429.
      View in: PubMed
    2. Ladwig NR, Schoolmeester JK, Weil L, Chapman JS, Zaloudek C, Umetsu SE. Inflammatory Myofibroblastic Tumor Associated With the Placenta: Short Tandem Repeat Genotyping Confirms Uterine Site of Origin. Am J Surg Pathol. 2018 Mar 02. PMID: 29505427.
      View in: PubMed
    3. Goode B, Joseph NM, Stevers M, Van Ziffle J, Onodera C, Talevich E, Grenert JP, Yeh I, Bastian BC, Phillips JJ, Garg K, Rabban JT, Zaloudek C, Solomon DA. Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation. Mod Pathol. 2018 Apr; 31(4):660-673. PMID: 29148537.
      View in: PubMed
    4. Nolan A, Joseph NM, Sangoi AR, Rabban J, Zaloudek C, Garg K. FOXL2 Mutation Status in Granulosa Theca Cell Tumors of the Ovary. Int J Gynecol Pathol. 2017 Nov; 36(6):568-574. PMID: 28319575.
      View in: PubMed
    5. Sangoi AR, Kshirsagar M, Roma AA, Horvai AE, Chivukula M, Ellenson LH, Fadare O, Folkins AK, Garg K, Hanley K, Longacre TA, Haas J, McCluggage WG, McKenney JK, Nucci MR, Oliva E, Park KJ, Parkash V, Quick CM, Rabban JT, Rutgers JKL, Soslow R, Vang R, Yemelyanova A, Zaloudek C, Beck AH. Interobserver Reproducibility Among Gynecologic Pathologists in Diagnosing Heterologous Osteosarcomatous Component in Gynecologic Tract Carcinosarcomas. Int J Gynecol Pathol. 2017 Jul; 36(4):386-392. PMID: 28221217.
      View in: PubMed
    6. Krings G, Joseph NM, Bean GR, Solomon D, Onodera C, Talevich E, Yeh I, Grenert JP, Hosfield E, Crawford ED, Jordan RC, van Zante A, Zaloudek C, Shin SJ, Chen YY. Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas. Mod Pathol. 2017 Aug; 30(8):1086-1099. PMID: 28548128.
      View in: PubMed
    7. Joseph NM, Chen YY, Nasr A, Yeh I, Talevich E, Onodera C, Bastian BC, Rabban JT, Garg K, Zaloudek C, Solomon DA. Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X. Mod Pathol. 2017 Feb; 30(2):246-254. PMID: 27813512.
      View in: PubMed
    8. Vang R, Levine DA, Soslow RA, Zaloudek C, Shih IeM, Kurman RJ. Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study. Int J Gynecol Pathol. 2016 Jan; 35(1):48-55. PMID: 26166714; PMCID: PMC4696053.
      View in: PubMed, PubMed Central
    9. Joseph NM, Solomon DA, Frizzell N, Rabban JT, Zaloudek C, Garg K. Morphology and Immunohistochemistry for 2SC and FH Aid in Detection of Fumarate Hydratase Gene Aberrations in Uterine Leiomyomas From Young Patients. Am J Surg Pathol. 2015 Nov; 39(11):1529-39. PMID: 26457356.
      View in: PubMed
    10. Rabban JT, Firetag B, Sangoi AR, Post MD, Zaloudek C. Incidental Pelvic and Para-aortic Lymph Node Lymphangioleiomyomatosis Detected During Surgical Staging of Pelvic Cancer in Women Without Symptomatic Pulmonary Lymphangioleiomyomatosis or Tuberous Sclerosis Complex. Am J Surg Pathol. 2015 Aug; 39(8):1015-25. PMID: 25786086.
      View in: PubMed
    11. Chapman JS, Asthana S, Cade L, Chang MT, Wang Z, Zaloudek C, Ueda S, Collisson EA, Taylor BS. Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course. J Natl Compr Canc Netw. 2015 Jul; 13(7):835-45. PMID: 26150578.
      View in: PubMed
    12. Rabban JT, Vohra P, Zaloudek C. Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia. Am J Surg Pathol. 2015 Jan; 39(1):35-51. PMID: 25025442.
      View in: PubMed
    13. Rabban JT, Garg K, Crawford B, Chen LM, Zaloudek C. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery. Am J Surg Pathol. 2014 Jun; 38(6):729-42. PMID: 24820399.
      View in: PubMed
    14. Can NT, Robertson P, Zaloudek C, Gill RM. Cervical squamous cell carcinoma metastatic to placenta. Int J Gynecol Pathol. 2013 Sep; 32(5):516-9. PMID: 23896714.
      View in: PubMed
    15. Karnezis AN, Aysal A, Zaloudek C, Rabban JT. Transitional cell-like morphology in ovarian endometrioid carcinoma: morphologic, immunohistochemical, and behavioral features distinguishing it from high-grade serous carcinoma. Am J Surg Pathol. 2013 Jan; 37(1):24-37. PMID: 23108017.
      View in: PubMed
    16. Rabban JT, Zaloudek C. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours. Histopathology. 2013 Jan; 62(1):71-88. PMID: 23240671.
      View in: PubMed
    17. Aysal A, Karnezis A, Medhi I, Grenert JP, Zaloudek C, Rabban JT. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability. Am J Surg Pathol. 2012 Feb; 36(2):163-72. PMID: 22189970.
      View in: PubMed
    18. Powell CB, Chen LM, McLennan J, Crawford B, Zaloudek C, Rabban JT, Moore DH, Ziegler J. Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol. Int J Gynecol Cancer. 2011 Jul; 21(5):846-51. PMID: 21670699.
      View in: PubMed
    19. Rabban JT, Mackey A, Powell CB, Crawford B, Zaloudek C, Chen LM. Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: implications for intraoperative specimen evaluation. Gynecol Oncol. 2011 Jun 01; 121(3):466-71. PMID: 21353295.
      View in: PubMed
    20. Rabban JT, Karnezis AN, Zaloudek C. Junctional epithelial zones of the fallopian tube: cancer hotspots? Int J Gynecol Pathol. 2011 Jan; 30(1):1-3. PMID: 21131841.
      View in: PubMed
    21. Rabban JT, McAlhany S, Lerwill MF, Grenert JP, Zaloudek C. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma. Am J Surg Pathol. 2010 Feb; 34(2):137-46. PMID: 20061933.
      View in: PubMed
    22. Rabban JT, Krasik E, Chen LM, Powell CB, Crawford B, Zaloudek C. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol. Am J Surg Pathol. 2009 Dec; 33(12):1878-85. PMID: 19898224.
      View in: PubMed
    23. Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek C. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma. Am J Surg Pathol. 2009 Aug; 33(8):1125-36. PMID: 19440148.
      View in: PubMed
    24. Rabban JT, Crawford B, Chen LM, Powell CB, Zaloudek C. Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations. Am J Surg Pathol. 2009 Jan; 33(1):111-9. PMID: 18830124.
      View in: PubMed
    25. Rabban JT, Lerwill MF, McCluggage WG, Grenert JP, Zaloudek C. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary. Int J Gynecol Pathol. 2009 Jan; 28(1):41-8. PMID: 19047909.
      View in: PubMed
    26. Hosfield EM, Rabban JT, Chen LM, Zaloudek C. Squamous metaplasia of the ovarian surface epithelium and subsurface fibrosis: distinctive pathologic findings in the ovaries and fallopian tubes of patients on peritoneal dialysis. Int J Gynecol Pathol. 2008 Oct; 27(4):465-74. PMID: 18753977.
      View in: PubMed
    27. Rabban JT, Zaloudek C. Minimal uterine serous carcinoma: current concepts in diagnosis and prognosis. Pathology. 2007 Feb; 39(1):125-33. PMID: 17365828.
      View in: PubMed
    28. Rabban JT, Gupta D, Zaloudek C, Chen LM. Synchronous ovarian granulosa cell tumor and uterine serous carcinoma: a rare association of a high-risk endometrial cancer with anestrogenic ovarian tumor. Gynecol Oncol. 2006 Dec; 103(3):1164-8. PMID: 17034837.
      View in: PubMed
    29. Rabban JT, Swain RS, Zaloudek C, Chase DR, Chen YY. Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markers. Mod Pathol. 2006 Oct; 19(10):1351-7. PMID: 16810311.
      View in: PubMed
    30. Cheng K, Pruitt L, Zaloudek C, Ries MD. Osteolysis caused by tibial component debonding in total knee arthroplasty. Clin Orthop Relat Res. 2006 Feb; 443:333-6. PMID: 16462459.
      View in: PubMed
    31. Rabban JT, Zaloudek C, Shekitka KM, Tavassoli FA. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors. Am J Surg Pathol. 2005 Oct; 29(10):1348-55. PMID: 16160478.
      View in: PubMed
    32. Hansen EK, Krieg RM, Azar RJ, Jablons DM, Jahan TM, Zaloudek C. Unusual thoracic problems in patients with malignancies: case 3. Carcinoid tumor of the thymus. J Clin Oncol. 2005 Apr 20; 23(12):2859-61. PMID: 15838001.
      View in: PubMed
    33. Powell CB, Kenley E, Chen LM, Crawford B, McLennan J, Zaloudek C, Komaromy M, Beattie M, Ziegler J. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. J Clin Oncol. 2005 Jan 01; 23(1):127-32. PMID: 15625367.
      View in: PubMed
    34. Heerema-McKenney A, Harrison MR, Bratton B, Farrell J, Zaloudek C. Congenital teratoma: a clinicopathologic study of 22 fetal and neonatal tumors. Am J Surg Pathol. 2005 Jan; 29(1):29-38. PMID: 15613854.
      View in: PubMed
    35. Pritts EA, Ryan IP, Mueller MD, Lebovic DI, Shifren JL, Zaloudek C, Korn AP, Darney PD, Taylor RN. Angiogenic effects of norplant contraception on endometrial histology and uterine bleeding. J Clin Endocrinol Metab. 2005 Apr; 90(4):2142-7. PMID: 15623808.
      View in: PubMed
    36. Huang MC, Lee HY, Yeh CC, Kong Y, Zaloudek C, Goetzl EJ. Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2). Oncogene. 2004 Jan 08; 23(1):122-9. PMID: 14712217.
      View in: PubMed
    37. Mueller MD, Pritts EA, Zaloudek C, Dreher E, Taylor RN. Regulation of vascular endothelial growth factor by tamoxifen in vitro and in vivo. Gynecol Obstet Invest. 2003; 55(2):119-24. PMID: 12771461.
      View in: PubMed
    38. Hu L, Hofmann J, Zaloudek C, Ferrara N, Hamilton T, Jaffe RB. Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer. Am J Pathol. 2002 Nov; 161(5):1917-24. PMID: 12414537; PMCID: PMC1850791.
      View in: PubMed, PubMed Central
    39. Geva E, Ginzinger DG, Zaloudek C, Moore DH, Byrne A, Jaffe RB. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab. 2002 Sep; 87(9):4213-24. PMID: 12213874.
      View in: PubMed
    Charles's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (230) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (39) people
    _
    Related Authors
    People who share related concepts with this person.
    See all (60) people
    _
    ↑